Assessment of PD-L1 expression and tumor associated immune cells in pediatric cancer tissues.

Authors:

Abstract
11542Background: PD-1 signaling in the tumor microenvironment dampens immune responses to cancer and blocking this axis induces anti-tumor effects in several malignancies. Expression of PD-L1 has been associated with poorer outcomes in certain cancers and may predict response to anti-PD-1 agents. Clinical studies of PD-1 blockade are only now being initiated in pediatric patients and little is known regarding PD-L1 expression in common childhood cancers. We characterized PD-L1 expression and Tumor Associated Immune Cells (TAIC, lymphocytes and macrophages) in common pediatric cancers. Methods: Whole slide sections (N = 91) and tissue microarrays (N = 529 cores) were evaluated by IHC for PD-L1 expression and for the presence of TAIC. A subset of 60 tumors was further assessed by multiplex immunohistochemistry (IHC) for CD3, CD4, CD8, CD45RO, PD-1, and FoxP3 expression. Results: Nine percent (39/451) of evaluable tumors expressed PD-L1 in at least 1% of tumor cells. Highest frequency histotypes were Burkitt...